The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.
ResMed Inc. (NYSE:RMD ) Q4 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Brett A. Sandercock - Chief Financial Officer Michael J.
![]() RMD In 3 days Announced | Quarterly | $0.6 Per Share |
![]() RMD 3 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 5 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 9 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 11 months ago Paid | Quarterly | $0.53 Per Share |
23 Oct 2025 (In 2 months) Date | | 2.5 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | 2.47 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
31 Jul 2025 Date | | 2.48 Cons. EPS | 2.55 EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
![]() RMD In 3 days Announced | Quarterly | $0.6 Per Share |
![]() RMD 3 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 5 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 9 months ago Paid | Quarterly | $0.53 Per Share |
![]() RMD 11 months ago Paid | Quarterly | $0.53 Per Share |
23 Oct 2025 (In 2 months) Date | | 2.5 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | 2.47 Cons. EPS | - EPS |
22 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
31 Jul 2025 Date | | 2.48 Cons. EPS | 2.55 EPS |
23 Apr 2025 Date | | - Cons. EPS | - EPS |
Medical - Instruments & Supplies Industry | Healthcare Sector | Michael J. Farrell BE, MBA, SM CEO | XHAN Exchange | US7611521078 ISIN |
US Country | 9,980 Employees | 14 Aug 2025 Last Dividend | 31 Aug 2010 Last Split | 2 Jun 1995 IPO Date |
ResMed Inc. is a pioneering company focused on developing, manufacturing, distributing, and marketing medical devices alongside cloud-based software applications tailored for the healthcare markets. With its operational base divided between Sleep and Respiratory Care, and Software as a Service (SaaS), ResMed is at the forefront of offering innovative solutions for managing respiratory disorders. The company's extensive product lineup and software solutions cater to both medical and consumer needs, aiming to improve patient outcomes through advanced technology and connectivity. Founded in 1989 and headquartered in San Diego, California, ResMed markets its products globally through a combination of direct sales forces and a network of distributors, targeting sleep clinics, home healthcare dealers, and hospitals.